A clinical OxyContin trial is in progress for children between the ages of 6 and 17, according to a CNN report. The trial will include 154 children with moderate to severe pain who have demonstrated a tolerance to opioids.
The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Study: Hospitals Struggle With Pediatric Pain
Pain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years
The Trump administration has imposed a plethora of tariffs for nearly all U.S. imports, with higher tariffs being placed on…
Virtual gastroenterology provider Oshi Health is offering patients a 100% return-on-investment guarantee. The new model puts 100% of Oshi’s fees…
Ashland, Ky.-based physician Matthew Lewis, MD, owner of Lewis Family Care, pleaded guilty to receiving and selling misbranded drugs with…
Comments are closed.